https://www.selleckchem.com/pr....oducts/rituximab.htm
Atrial fibrillation (AF) is the most common heart rhythm disturbance, continues to increase in incidence, and results in significant morbidity and mortality. The marine omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and vitamin D have been reported to have both benefits and risks with respect to incident AF, but large-scale, long-term randomized trial data are lacking. To test the effects of long-term administration of marine omega-3 fatty acids and vitamin D on incident AF. An ancillary study of a 2
إعجاب
علق
شارك
